Insmed (INSM) Receivables (2010 - 2026)

Insmed's Receivables history runs 11 years deep, the most recent figure standing at $178.6 million for Q1 2026.

• In Q1 2026, Receivables rose 273.97% year-over-year to $178.6 million; the TTM figure through Mar 2026 stood at $178.6 million (up 273.97% YoY), while the FY2025 annual figure was $140.9 million, up 170.82% from the prior year.
• Receivables was $178.6 million for Q1 2026 at Insmed, up from $140.9 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $178.6 million in Q1 2026 to a low of $25.7 million in Q1 2022.
• Historically, Receivables has averaged $53.5 million across 5 years, with a median of $40.3 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Receivables increased 4.97% in 2023, then jumped 273.97% in 2026.
• A 5-year view of Receivables shows it stood at $29.7 million in 2022, then soared by 38.62% to $41.2 million in 2023, then climbed by 26.28% to $52.0 million in 2024, then soared by 170.82% to $140.9 million in 2025, then climbed by 26.76% to $178.6 million in 2026.
• The last three Receivables figures came in at $178.6 million (Q1 2026), $140.9 million (Q4 2025), and $65.3 million (Q3 2025), per Business Quant data.